Dermatologicals Market to Reach $36.20 Bn, Globally, by 2026 at 10.9% CAGR: Allied Market Research

Rise in prevalence of skin disorders, surge in healthcare expenditure, and increase in focus on skincare products have boosted the growth of the global dermatologicals market

News provided by

Allied Market Research

Apr 15, 2020, 10:10 ET

PORTLAND, Oregon, April 15, 2020 /PRNewswire/ -- Allied Market Research recently published a report, titled, "Dermatologicals Market by Dermatological Disease (Acne, Dermatitis, Psoriasis, Skin Cancer, Rosacea, and Alopecia), Drug Type (Prescription-Based Drugs and Over-the-Counter Drugs), and Route of Administration (Topical, Oral, and Parenteral Administration), Global Opportunity Analysis and Industry Forecast, 2018–2026". According to the report, the global dermatologicals industry was pegged at $15.56 billion in 2018, and is anticipated to reach $36.20 billion by 2026, growing at a CAGR of 10.9% from 2019 to 2026.

Drivers, restraints, and opportunities

Rise in prevalence of skin disorders, surge in healthcare expenditure, and increase in focus on skincare products have boosted the growth of the global dermatologicals market. However, presence of alternatives for acne treatment hampers the market growth. On the contrary, high growth potential in developing economies is expected to create lucrative opportunities in the near future.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/3805

Dermatitis segment to manifest the highest CAGR through 2026

The dermatitis segment is expected to register the fastest CAGR of 11.8% during the forecast period, due to surge in the awareness related to the use of dermatologicals for the treatment of dermatitis across the globe. However, the psoriasis segment held the largest share in 2018, contributing to nearly two-fifths of the global dermatologicals market, owing to increase in the incidences of psoriasis along with skin disorders associated with it and rise in awareness among people regarding different treatments.

Prescription-based drugs segment dominated the market

The prescription-based drugs segment held the largest share in 2018, accounting for nearly two-thirds of the global dermatologicals market, as these medicines are advantageous as patients get the correct dosage of the drug during the treatment of skin conditions such as acne and psoriasis. However, the over-the-counter drugs segment is expected to portray the highest CAGR of 11.7% during the forecast period, owing to rise in awareness related to early diagnosis and treatment of the medical condition.

North America held the lion's share

The market across North America held the largest share in 2018, contributing to around two-fifths of the total revenue. This is pertaining to surge in prevalence of various skin disorders, easy availability of dermatological products and surge in awareness related to use of dermatologicals in treatment of various skin disorders. However, the global dermatologicals market across Asia-Pacific is anticipated to register the highest CAGR of 12.3% during the forecast period, due to presence of large potential customer base coupled with surge in awareness related to use of dermatologicals for treatment of diseases.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/3805

Major market players

Bayer AG
Pfizer Inc.
Johnson & Johnson
GlaxoSmithKline plc
Novartis AG
Galderma S.A.
AstraZeneca
AbbVie Inc.
Amgen Inc.
Merck KGaA

Access AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/library-access

Avenue is a user-based library of global market report database, provides comprehensive reports pertaining to the world's largest emerging markets. It further offers e-access to all the available industry reports just in a jiffy. By offering core business insights on the varied industries, economies, and end users worldwide, Avenue ensures that the registered members get an easy as well as single gateway to their all-inclusive requirements.

Avenue Library Subscription | Request for 14 days free trial of before buying:

https://www.alliedmarketresearch.com/avenue/trial/starter

TAVI Market Global Opportunity Analysis and Industry Forecast, 2019–2026

Electrocardiograph (ECG) Market Global Opportunity Analysis and Industry Forecast, 2019–2026

Immunoglobulin Market Global Opportunity Analysis and Industry Forecast, 2019–2026

Medical Laser Market Global Opportunity Analysis and Industry Forecast, 2019–2026

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022, 1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research